Passage BIO, Inc. - 8-K Filing
Passage Bio amends merger agreement with Remix Therapeutics to implement a two-step structure and pre-funded warrants for $70M concurrent financing. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $PASG